Your session is about to expire
← Back to Search
ANC-501 for Major Depressive Disorder
Study Summary
This trial will test a new drug for safety and effectiveness in people with major depression.
- Depression
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of bipolar disorder, schizophrenia, or schizoaffective disorder.Your current antidepressant medication is not working for you, even after trying different doses or making changes to the treatment plan.Your depression symptoms are severe, with a score of 28 or higher on a mood assessment test.You have tried at least two different treatments for your condition for at least 6 weeks each, but none of them have worked well enough.
- Group 1: ANC-501
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the eligibility criteria for this experiment restricted to individuals under 75 years of age?
"This clinical trial is recruiting volunteers who are of legal age (18+) and below the retirement threshold (65)."
Are there any available slots in this investigation that a patient could occupy?
"Indeed, as seen on clinicaltrials.gov this research project is presently engaging enrollees. This investigation was first announced on September 19th 2022 and the details have been updated in October of the same year."
What perils have been associated with ANC-501?
"Due to the lack of clinical data indicating efficacy, ANC-501 has been assigned a score of 2 in regards to safety. This is because it is only currently undergoing Phase 2 trials."
Who is eligible to join in this medical experiment?
"Qualified applicants to this medical experiment must have a diagnosis of major depressive disorder and be within the ages 18-65. It is estimated that 20 individuals will meet these criteria for enrolment."
What is the scope of participants in this research endeavor?
"Affirmative, the clinicaltrials.gov database notes that this medical trial commenced on September 19th 2022 and latest updates were posted on October 19th of the same year. The research is recruiting a total of 20 participants from three different locations."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger